Skip to main content

United Immunity

Tokyo, Japan

United Immunity is a research firm that specializes in development, and supply of pharmaceuticals, mainly for cancer immunotherapy.

$1.2M raised
Mar 2024
Debt Financing

Top Investors

Mitsubishi UFJ CapitalUTEC - The University of Tokyo Edge Capital PartnersAozora Corporate InvestmentSaisei VenturesAxil Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about United Immunity

How much funding has United Immunity raised?
United Immunity has raised $1.2M in total funding. The most recent round was Debt Financing. The last funding was announced in March 2024.
Who are United Immunity's investors?
United Immunity's investors include Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, Aozora Corporate Investment, Saisei Ventures, Axil Capital.
Where is United Immunity headquartered?
United Immunity is headquartered in Tokyo, Japan.
What does United Immunity do?
United Immunity is a research firm that specializes in development, and supply of pharmaceuticals, mainly for cancer immunotherapy.
What stage is United Immunity at?
United Immunity is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"United Immunity — Funding & Investors." VCBacked, March 18, 2024, https://www.vcbacked.co/company/united-immunity. Accessed July 1, 2026.
APA
VCBacked. (2024). United Immunity — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/united-immunity
Wikipedia (cite web)
{{cite web |title=United Immunity — Funding & Investors |url=https://www.vcbacked.co/company/united-immunity |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .